Chief Medical Officer · Neurogene Inc. (NGNE)

Priti Patel

FY2021 is the first fiscal year CompBrief holds for Priti Patel as a named executive officer of Neurogene; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$5,410,163

Salary $294,556Stock awards $4,897,435Bonus $100,000

1st of 3 named executive officers at Neurogene by FY2021 total.

3 named officers on file for Neurogene, FY2021

Priti Patel’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Neurogene’s whole pay program stands against its peers

  • Neurogene’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NGNE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 31, 2022 (DEF 14A).

Free

Get Priti Patel’s full pay file as a PDF — free

More than this page: up to 10 years of Priti’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Priti Patel compensation by year

Neurogene Summary Compensation Table · the one fiscal year held
In US dollars, as Neurogene reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$294,556
Bonus$100,000
Stock awards$4,897,435
Option awards$0
Non-equity incentive$115,466
Pension and deferred compensation$0
All other$2,706
Total$5,410,163

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Neurogene Inc. DEF 14A filed March 31, 2022, accession 0001628280-22-008017, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Neurogene Inc. filed document, accession 0001628280-22-008017. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option50,000—$6.80
Option475,000—$12.49
Option20,000—$0.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Neurogene Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Neurogene’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Priti Patel · this pageChief Medical Officer$5,410,163
Jonathan DrachmanChief Executive Officer$2,650,131
Robert HoFormer Chief Financial Officer$1,505,433

The full Neurogene compensation record

free company brief

This page is one person within Neurogene's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Neurogene's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Priti Patel's compensation dossier · One-time report. No refunds.